Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 828

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

European Association of Urology Guidelines on Sexual and Reproductive Health—2021 Update: Male Sexual Dysfunction

Open access
Salonia, Andrea, Bettocchi, Carlo, Boeri, Luca, Capogrosso, Paolo, Carvalho, Joana, Cilesiz, Nusret Can, Cocci, Andrea, Corona, Giovanni, Dimitropoulos, Kostantinos, Gül, Murat, Hatzichristodoulou, Georgios, Jones, T. Hugh, Kadioglu, Ates, Martínez Salamanca, Juan Ignatio, Milenkovic, Uros, Modgil, Vaibhav, Russo, Giorgio Ivan, Serefoglu, Ege Can, Tharakan, Tharu, Verze, Paolo, Minhas, Suks·2021·European Urology
DOI 10.1016/j.eururo.2021.06.007
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.eururo.2021.06.007

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Research works printed but not linked: 179

  1. Hatzimouratidis, 2012, EAU guidelines on penile curvature, Eur Urol, 62, 543, 10.1016/j.eururo.2012.05.040 · DOI · Paper page
  2. Guyatt, 2008, Going from evidence to recommendations, BMJ, 336, 1049, 10.1136/bmj.39493.646875.AE · DOI · Paper page
  3. Zarotsky, 2014, Systematic literature review of the risk factors, comorbidities, and consequences of hypogonadism in men, Andrology, 2, 819, 10.1111/andr.274 · DOI · Paper page
  4. Maseroli, 2015, Prevalence of endocrine and metabolic disorders in subjects with erectile dysfunction: a comparative study, J Sex Med, 12, 956, 10.1111/jsm.12832 · DOI
  5. Kanakis, 2018, Klinefelter syndrome: more than hypogonadism, Metabolism, 86, 135, 10.1016/j.metabol.2017.09.017 · DOI · Paper page
  6. Corona, 2020, Subclinical male hypogonadism, Minerva Endocrinol, 10.23736/S0391-1977.20.03208-3 · DOI
  7. Grossmann, 2017, A perspective on middle-aged and older men with functional hypogonadism: focus on holistic management, J Clin Endocrinol Metab, 102, 1067, 10.1210/jc.2016-3580 · DOI · Paper page
  8. Gagliano-Jucá, 2019, Oral glucose load and mixed meal feeding lowers testosterone levels in healthy eugonadal men, Endocrine, 63, 149, 10.1007/s12020-018-1741-y · DOI
  9. Huhtaniemi, 2012, Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men, Eur J Endocrinol, 166, 983, 10.1530/EJE-11-1051 · DOI · Paper page
  10. Corona, 2017, Meta-analysis of results of testosterone therapy on sexual function based on International Index of Erectile Function scores, Eur Urol, 72, 1000, 10.1016/j.eururo.2017.03.032 · DOI · Paper page
  11. Isidori, 2014, A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment—a systematic review, Eur Urol, 65, 99, 10.1016/j.eururo.2013.08.048 · DOI · Paper page
  12. Boeri, 2017, Does calculated free testosterone overcome total testosterone in protecting from sexual symptom impairment? Findings of a cross-sectional study, J Sex Med, 14, 1549, 10.1016/j.jsxm.2017.10.070 · DOI
  13. Isidori, 2015, Outcomes of androgen replacement therapy in adult male hypogonadism: recommendations from the Italian Society of Endocrinology, J Endocrinol Invest, 38, 103, 10.1007/s40618-014-0155-9 · DOI
  14. Molitch, 2017, Diagnosis and treatment of pituitary adenomas: a review, JAMA, 317, 516, 10.1001/jama.2016.19699 · DOI · Paper page
  15. Millar, 2016, Predicting low testosterone in aging men: a systematic review, CMAJ Can Med Assoc J, 188, E321, 10.1503/cmaj.150262 · DOI
  16. Rastrelli, 2019, Testosterone and benign prostatic hyperplasia, Sex Med Rev, 7, 259, 10.1016/j.sxmr.2018.10.006 · DOI
  17. Shabsigh, 2009, Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review, Int J Impot Res, 21, 9, 10.1038/ijir.2008.31 · DOI
  18. Morelli, 2007, Which patients with sexual dysfunction are suitable for testosterone replacement therapy?, J Endocrinol Invest, 30, 880, 10.1007/BF03349232 · DOI
  19. Colpi, 2018, European Academy of Andrology guideline management of oligo-astheno-teratozoospermia, Andrology, 6, 513, 10.1111/andr.12502 · DOI · Paper page
  20. Rastrelli, 2019, Testosterone replacement therapy for sexual symptoms, Sex Med Rev, 7, 464, 10.1016/j.sxmr.2018.11.005 · DOI
  21. Elliott, 2017, Testosterone therapy in hypogonadal men: a systematic review and network meta-analysis, BMJ Open, 7, 10.1136/bmjopen-2016-015284 · DOI
  22. Corona, 2016, Testosterone supplementation and body composition: results from a meta-analysis of observational studies, J Endocrinol Invest, 39, 967, 10.1007/s40618-016-0480-2 · DOI · Paper page
  23. Rosen, 2017, Quality of life and sexual function benefits of long-term testosterone treatment: longitudinal results from the Registry of Hypogonadism in Men (RHYME), J Sex Med, 14, 1104, 10.1016/j.jsxm.2017.07.004 · DOI
  24. Smith, 2018, Low serum testosterone in outpatient psychiatry clinics: addressing challenges to the screening and treatment of hypogonadism, Sex Med Rev, 6, 69, 10.1016/j.sxmr.2017.08.007 · DOI
  25. Walther, 2019, Association of testosterone treatment with alleviation of depressive symptoms in men: a systematic review and meta-analysis, JAMA Psychiatry, 76, 31, 10.1001/jamapsychiatry.2018.2734 · DOI · Paper page
  26. Nian, 2017, Testosterone replacement therapy improves health-related quality of life for patients with late-onset hypogonadism: a meta-analysis of randomized controlled trials, Andrologia, 49, 10.1111/and.12630 · DOI
  27. Corona, 2021, Testosterone deficiency and risk of cognitive disorders in aging males, World J Mens Health, 39, 9, 10.5534/wjmh.200017 · DOI
  28. Rochira, 2018, EAA clinical guideline on management of bone health in the andrological outpatient clinic, Andrology, 6, 272, 10.1111/andr.12470 · DOI
  29. Isidori, 2005, Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis, Clin Endocrinol (Oxf), 63, 280, 10.1111/j.1365-2265.2005.02339.x · DOI · Paper page
  30. Steeves, 2016, Cross-sectional association between physical activity and serum testosterone levels in US men: results from NHANES 1999–2004, Andrology, 4, 465, 10.1111/andr.12169 · DOI
  31. Corona, 2018, Deciding which testosterone therapy to prescribe, J Sex Med, 15, 619, 10.1016/j.jsxm.2018.02.006 · DOI
  32. Kohn, 2016, Effects of testosterone replacement therapy on lower urinary tract symptoms: a systematic review and meta-analysis, Eur Urol, 69, 1083, 10.1016/j.eururo.2016.01.043 · DOI
  33. Kathrins, 2016, The relationship between testosterone-replacement therapy and lower urinary tract symptoms: a systematic review, Urology, 88, 22, 10.1016/j.urology.2015.11.006 · DOI
  34. Lopez, 2017, Endogenous and exogenous testosterone and prostate cancer: decreased-, increased- or null-risk?, Transl Androl Urol, 6, 566, 10.21037/tau.2017.05.35 · DOI
  35. Watts, 2018, Low free testosterone and prostate cancer risk: a collaborative analysis of 20 prospective studies, Eur Urol, 74, 585, 10.1016/j.eururo.2018.07.024 · DOI
  36. Haider, 2015, Incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registries, J Urol, 193, 80, 10.1016/j.juro.2014.06.071 · DOI
  37. Teeling, 2019, Testosterone therapy for high-risk prostate cancer survivors: a systematic review and meta-analysis, Urology, 126, 16, 10.1016/j.urology.2018.07.064 · DOI
  38. Corona, 2018, Endogenous testosterone levels and cardiovascular risk: meta-analysis of observational studies, J Sex Med, 15, 1260, 10.1016/j.jsxm.2018.06.012 · DOI · Paper page
  39. Alexander, 2017, Cardiovascular risks of exogenous testosterone use among men: a systematic review and meta-analysis, Am J Med, 130, 293, 10.1016/j.amjmed.2016.09.017 · DOI
  40. Corona, 2014, Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis, Expert Opin Drug Saf, 13, 1327, 10.1517/14740338.2014.950653 · DOI · Paper page
  41. Calof, 2005, Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials, J Gerontol A Biol Sci Med Sci, 60, 1451, 10.1093/gerona/60.11.1451 · DOI · Paper page
  42. Puddu, 2002, Red blood cell count in short-term prediction of cardiovascular disease incidence in the Gubbio population study, Acta Cardiol, 57, 177, 10.2143/AC.57.3.2005387 · DOI
  43. NIH Consensus Conference, 1993, Impotence. NIH Consensus Development Panel on impotence, JAMA, 270, 83, 10.1001/jama.1993.03510010089036 · DOI · Paper page
  44. Eardley, 2013, The incidence, prevalence, and natural history of erectile dysfunction, Sex Med Rev, 1, 3, 10.1002/smrj.2 · DOI
  45. Gandaglia, 2014, A systematic review of the association between erectile dysfunction and cardiovascular disease, Eur Urol, 65, 968, 10.1016/j.eururo.2013.08.023 · DOI · Paper page
  46. Besiroglu, 2015, The relationship between metabolic syndrome, its components, and erectile dysfunction: a systematic review and a meta-analysis of observational studies, J Sex Med, 12, 1309, 10.1111/jsm.12885 · DOI
  47. Pozzi, 2020, Longitudinal risk of developing cardiovascular diseases in patients with erectile dysfunction—which patients deserve more attention?, J Sex Med, 17, 1489, 10.1016/j.jsxm.2020.03.012 · DOI
  48. Pizzol, 2020, Associations between body mass index, waist circumference and erectile dysfunction: a systematic review and META-analysis, Rev Endocr Metab Disord, 21, 657, 10.1007/s11154-020-09541-0 · DOI
  49. Alberti, 2013, Erectile dysfunction in heart failure patients: a critical reappraisal, Andrology, 1, 177, 10.1111/j.2047-2927.2012.00048.x · DOI
  50. Carani, 2005, Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients, J Clin Endocrinol Metab, 90, 6472, 10.1210/jc.2005-1135 · DOI · Paper page
  51. Corona, 2012, Thyroid hormones and male sexual function, Int J Androl, 35, 668, 10.1111/j.1365-2605.2012.01266.x · DOI
  52. Corona, 2016, Endocrinologic control of men’s sexual desire and arousal/erection, J Sex Med, 13, 317, 10.1016/j.jsxm.2016.01.007 · DOI · Paper page
  53. Corona, 2007, Effect of hyperprolactinemia in male patients consulting for sexual dysfunction, J Sex Med, 4, 1485, 10.1111/j.1743-6109.2007.00569.x · DOI
  54. Duran, 2021, Variations in the number of patients presenting with andrological problems during the COVID-19 pandemic and the possible reasons for these variations: a multi-center study, Sex Med, 9
  55. Sansone, 2021, Addressing male sexual and reproductive health in the wake of COVID-19 outbreak, J Endocrinol Invest, 44, 223, 10.1007/s40618-020-01350-1 · DOI · Paper page
  56. Cui, 2014, The effect of statins on erectile dysfunction: a systematic review and meta-analysis, J Sex Med, 11, 1367, 10.1111/jsm.12497 · DOI
  57. Rosen, 2003, Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7), Eur Urol, 44, 637, 10.1016/j.eururo.2003.08.015 · DOI · Paper page
  58. Seftel, 2013, Coexisting lower urinary tract symptoms and erectile dysfunction: a systematic review of epidemiological data, Int J Clin Pract, 67, 32, 10.1111/ijcp.12044 · DOI
  59. Verze, 2019, The impact of surgery for lower urinary tract symptoms/benign prostatic enlargement on both erectile and ejaculatory function: a systematic review, Int J Impot Res, 31, 319, 10.1038/s41443-019-0140-0 · doi:10.1038/s41443-019-0140-0
  60. Li, 2016, The impact of surgical treatments for lower urinary tract symptoms/benign prostatic hyperplasia on male erectile function: a systematic review and network meta-analysis, Medicine (Baltimore), 95, e3862, 10.1097/MD.0000000000003862 · DOI
  61. Chung, 2013, A nationwide population-based study on bladder pain syndrome/interstitial cystitis and ED., Int J Impot Res, 25, 224, 10.1038/ijir.2013.15 · DOI
  62. Chen, 2015, The effect of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) on erectile function: a systematic review and meta-analysis, PLoS One, 10
  63. Murray, 2015, A prospective study of erectile function after transrectal ultrasonography-guided prostate biopsy, BJU Int, 116, 190, 10.1111/bju.13002 · DOI
  64. Feng, 2013, The relationship between erectile dysfunction and open urethroplasty: a systematic review and meta-analysis, J Sex Med, 10, 2060, 10.1111/jsm.12181 · DOI
  65. Emanu, 2016, Erectile dysfunction after radical prostatectomy: prevalence, medical treatments, and psychosocial interventions, Curr Opin Support Palliat Care, 10, 102, 10.1097/SPC.0000000000000195 · DOI
  66. Salonia, 2017, Sexual rehabilitation after treatment for prostate cancer—part 1: recommendations from the Fourth International Consultation for Sexual Medicine (ICSM 2015), J Sex Med, 14, 285, 10.1016/j.jsxm.2016.11.325 · DOI
  67. Modh, 2014, Sexual dysfunction after cystectomy and urinary diversion, Nat Rev Urol, 11, 445, 10.1038/nrurol.2014.151 · DOI
  68. Celentano, 2010, Prospective study of sexual dysfunction in men with rectal cancer: feasibility and results of nerve sparing surgery, Int J Colorectal Dis, 25, 1441, 10.1007/s00384-010-0995-5 · DOI
  69. Walz, 2016, A critical analysis of the current knowledge of surgical anatomy of the prostate related to optimisation of cancer control and preservation of continence and erection in candidates for radical prostatectomy: an update, Eur Urol, 70, 301, 10.1016/j.eururo.2016.01.026 · DOI · Paper page
  70. Moran, 2013, Robot-assisted radical prostatectomy compared with open and laparoscopic approaches: a systematic review and meta-analysis, Int J Urol, 20, 312, 10.1111/iju.12070 · DOI
  71. Ficarra, 2012, Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy, Eur Urol, 62, 418, 10.1016/j.eururo.2012.05.046 · DOI · Paper page
  72. Capogrosso, 2020, Erectile recovery after radical pelvic surgery: methodological challenges and recommendations for data reporting, J Sex Med, 17, 7, 10.1016/j.jsxm.2019.09.013 · DOI
  73. Isgoren, 2014, Erectile function outcomes after robot-assisted radical prostatectomy: is it superior to open retropubic or laparoscopic approach?, Sex Med Rev, 2, 10, 10.1002/smrj.21 · DOI
  74. Yaxley, 2016, Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study, Lancet Lond Engl, 388, 1057, 10.1016/S0140-6736(16)30592-X · DOI · Paper page
  75. Hunt, 2021, Risk of erectile dysfunction after modern radiotherapy for intact prostate cancer, Prostate Cancer Prostatic Dis, 24, 128, 10.1038/s41391-020-0247-x · DOI
  76. Nolsøe, 2021, Neglected side effects to curative prostate cancer treatments, Int J Impot Res, 33, 428, 10.1038/s41443-020-00386-4 · DOI
  77. Valerio, 2017, New and established technology in focal ablation of the prostate: a systematic review, Eur Urol, 71, 17, 10.1016/j.eururo.2016.08.044 · DOI · Paper page
  78. Maggi, 2019, Psychological impact of different primary treatments for prostate cancer: a critical analysis, Andrologia, 51, 10.1111/and.13157 · DOI
  79. Hatzichristou, 2016, Diagnosing sexual dysfunction in men and women: sexual history taking and the role of symptom scales and questionnaires, J Sex Med, 13, 1166, 10.1016/j.jsxm.2016.05.017 · DOI · Paper page
  80. Althof, 2013, Standard operating procedures for taking a sexual history, J Sex Med, 10, 26, 10.1111/j.1743-6109.2012.02823.x · DOI
  81. Rosen, 2002, The International Index of Erectile Function (IIEF): a state-of-the-science review, Int J Impot Res, 14, 226, 10.1038/sj.ijir.3900857 · DOI · Paper page
  82. Mulhall, 2007, Validation of the erection hardness score, J Sex Med, 4, 1626, 10.1111/j.1743-6109.2007.00600.x · DOI · Paper page
  83. Richter, 1998, On the validity of the Beck Depression Inventory. A review, Psychopathology, 31, 160, 10.1159/000066239 · DOI · Paper page
  84. Zhao, 2019, Erectile dysfunction predicts cardiovascular events as an independent risk factor: a systematic review and meta-analysis, J Sex Med, 16, 1005, 10.1016/j.jsxm.2019.04.004 · DOI
  85. Poorthuis, 2017, Female- and male-specific risk factors for stroke: a systematic review and meta-analysis, JAMA Neurol, 74, 75, 10.1001/jamaneurol.2016.3482 · DOI · Paper page
  86. Chokesuwattanaskul, 2018, Erectile dysfunction and atrial fibrillation: a systematic review and meta-analysis, Int J Urol, 25, 752, 10.1111/iju.13725 · doi:10.1111/iju.13725
  87. Nehra, 2012, The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease, Mayo Clin Proc, 87, 766, 10.1016/j.mayocp.2012.06.015 · DOI · Paper page
  88. Ghanem, 2013, SOP: physical examination and laboratory testing for men with erectile dysfunction, J Sex Med, 10, 108, 10.1111/j.1743-6109.2012.02734.x · DOI
  89. Maggi, 2013, Hormonal causes of male sexual dysfunctions and their management (hyperprolactinemia, thyroid disorders, GH disorders, and DHEA), J Sex Med, 10, 661, 10.1111/j.1743-6109.2012.02735.x · DOI
  90. Zou, 2019, The role of nocturnal penile tumescence and rigidity (NPTR) monitoring in the diagnosis of psychogenic erectile dysfunction: a review, Sex Med Rev, 7, 442, 10.1016/j.sxmr.2018.10.005 · DOI
  91. Hatzichristou, 1998, Nocturnal penile tumescence and rigidity monitoring in young potent volunteers: reproducibility, evaluation criteria and the effect of sexual intercourse, J Urol, 159, 1921, 10.1016/S0022-5347(01)63197-5 · DOI
  92. Edgar R, Trip EJ, Wolterink GJW, Veltink PH, Beck JJH. New methods for the monitoring of nocturnal erections. Int J Impot Res. In press. https://doi.org/10.1038/s41443-020-00365-9. · doi:10.1038/s41443-020-00365-9
  93. Qin, 2018, Advantages and limitations of sleep-related erection and rigidity monitoring: a review, Int J Impot Res, 30, 192, 10.1038/s41443-018-0032-8 · DOI
  94. Nascimento, 2020, A critical analysis of methodology pitfalls in duplex Doppler ultrasound in the evaluation of patients with erectile dysfunction: technical and interpretation deficiencies, J Sex Med, 17, 1416, 10.1016/j.jsxm.2020.05.023 · DOI
  95. Capogrosso, 2019, Low-intensity shock wave therapy in sexual medicine-clinical recommendations from the European Society of Sexual Medicine (ESSM), J Sex Med, 16, 1490, 10.1016/j.jsxm.2019.07.016 · DOI
  96. Trost, 2016, External mechanical devices and vascular surgery for erectile dysfunction, J Sex Med, 13, 1579, 10.1016/j.jsxm.2016.09.008 · DOI
  97. Nguyen, 2017, Erectile dysfunction in young men—a review of the prevalence and risk factors, Sex Med Rev, 5, 508, 10.1016/j.sxmr.2017.05.004 · DOI · Paper page
  98. Hatzimouratidis, 2016, Pharmacotherapy for erectile dysfunction: recommendations from the Fourth International Consultation for Sexual Medicine (ICSM 2015), J Sex Med, 13, 465, 10.1016/j.jsxm.2016.01.016 · DOI · Paper page
  99. Kloner, 2018, Cardiovascular safety of phosphodiesterase type 5 inhibitors after nearly 2 decades on the market, Sex Med Rev, 6, 583, 10.1016/j.sxmr.2018.03.008 · DOI
  100. Adamou, 2020, The hemodynamic interactions of combination therapy with α-blockers and phosphodiesterase-5 inhibitors compared to monotherapy with α-blockers: a systematic review and meta-analysis, Int Urol Nephrol, 52, 1407, 10.1007/s11255-020-02454-6 · doi:10.1007/s11255-020-02454-6
  101. Sakuma, 2002, Interactions of sildenafil with various coronary vasodilators in isolated porcine coronary artery, Eur J Pharmacol, 437, 155, 10.1016/S0014-2999(01)01622-3 · doi:10.1016/s0014-2999(01)01622-3
  102. Ishizuka, 2000, Hypotensive interaction of sildenafil and nicorandil in rats through the cGMP pathway but not by K(ATP) channel activation, Jpn J Pharmacol, 84, 316, 10.1254/jjp.84.316 · doi:10.1254/jjp.84.316
  103. Anaissie, 2016, Clinical use of alprostadil topical cream in patients with erectile dysfunction: a review, Res Rep Urol, 8, 123
  104. Cai, 2019, The intra-meatal application of alprostadil cream (Vitaros®) improves drug efficacy and patient’s satisfaction: results from a randomized, two-administration route, cross-over clinical trial, Int J Impot Res, 31, 119, 10.1038/s41443-018-0087-6 · DOI
  105. Coombs, 2012, A review of outcomes of an intracavernosal injection therapy programme, BJU Int, 110, 1787, 10.1111/j.1464-410X.2012.11080.x · DOI
  106. Duncan, 2019, Erectile dysfunction: a global review of intracavernosal injectables, World J Urol, 37, 1007, 10.1007/s00345-019-02727-5 · DOI
  107. Porst, 2013, SOP conservative (medical and mechanical) treatment of erectile dysfunction, J Sex Med, 10, 130, 10.1111/jsm.12023 · DOI · Paper page
  108. Eardley, 2010, Pharmacotherapy for erectile dysfunction, J Sex Med, 7, 524, 10.1111/j.1743-6109.2009.01627.x · DOI · Paper page
  109. Porst, 2000, Current perspectives on intracavernosal pharmacotherapy for erectile dysfunction, Int J Impot Res, 12, S91, 10.1038/sj.ijir.3900585 · doi:10.1038/sj.ijir.3900585
  110. Vardi, 2010, Can low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction, Eur Urol, 58, 243, 10.1016/j.eururo.2010.04.004 · DOI · Paper page
  111. Sokolakis, 2019, Clinical studies on low intensity extracorporeal shockwave therapy for erectile dysfunction: a systematic review and meta-analysis of randomised controlled trials, Int J Impot Res, 31, 177, 10.1038/s41443-019-0117-z · DOI
  112. Bechara, 2016, Twelve-month efficacy and safety of low-intensity shockwave therapy for erectile dysfunction in patients who do not respond to phosphodiesterase type 5 inhibitors, Sex Med, 4, e225, 10.1016/j.esxm.2016.06.001 · DOI
  113. Vinay J, Moreno D, Rajmil O, Ruiz-Castañe E, Sanchez-Curbelo J. Penile low intensity shock wave treatment for PDE5I refractory erectile dysfunction: a randomized double-blind sham-controlled clinical trial. World J Urol. In press. https://doi.org/10.1007/s00345-020-03373-y. · DOI
  114. Campbell, 2019, Meta-analysis of randomized controlled trials that assess the efficacy of low-intensity shockwave therapy for the treatment of erectile dysfunction, Ther Adv Urol, 11, 10.1177/1756287219838364 · DOI
  115. Yuan, 2010, Vacuum therapy in erectile dysfunction—science and clinical evidence, Int J Impot Res, 22, 211, 10.1038/ijir.2010.4 · DOI
  116. Cavallini, 2017, Resolution of erectile dysfunction after an andrological visit in a selected population of patients affected by psychogenic erectile dysfunction, Asian J Androl, 19, 219, 10.4103/1008-682X.172646 · DOI
  117. Bajic, 2020, Etiology of erectile dysfunction and duration of symptoms in patients undergoing penile prosthesis: a systematic review, Sex Med Rev, 8, 333, 10.1016/j.sxmr.2019.05.003 · DOI
  118. Muneer, 2021, UK practice for penile prosthesis surgery: baseline analysis of the British Association of Urological Surgeons (BAUS) penile prosthesis audit, BJU Int, 127, 326, 10.1111/bju.15219 · DOI
  119. Palmisano, 2018, Comparison of infrapubic vs penoscrotal approaches for 3-piece inflatable penile prosthesis placement: do we have a winner?, Sex Med Rev, 6, 631, 10.1016/j.sxmr.2018.03.007 · DOI
  120. Otero, 2017, Comparison of the patient and partner satisfaction with 700CX and Titan penile prostheses, Asian J Androl, 19, 321, 10.4103/1008-682X.172822 · DOI
  121. Chierigo, 2019, Long-term follow-up after penile prosthesis implantation-survival and quality of life outcomes, J Sex Med, 16, 1827, 10.1016/j.jsxm.2019.08.001 · DOI
  122. Pisano, 2015, The importance of psychosexual counselling in the re-establishment of organic and erotic functions after penile prosthesis implantation, Int J Impot Res, 27, 197, 10.1038/ijir.2015.17 · doi:10.1038/ijir.2015.17
  123. Atri, 2020, A comparison between AMS 700 and Coloplast Titan: a systematic literature review, Cureus, 12
  124. Serefoglu, 2014, An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine Ad Hoc Committee for the definition of premature ejaculation, J Sex Med, 11, 1423, 10.1111/jsm.12524 · DOI · Paper page
  125. Waldinger, 2006, Changing paradigms from a historical DSM-III and DSM-IV view toward an evidence-based definition of premature ejaculation. Part II—proposals for DSM-V and ICD-11, J Sex Med, 3, 693, 10.1111/j.1743-6109.2006.00276.x · DOI · Paper page
  126. Porst, 2007, The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking, Eur Urol, 51, 816, 10.1016/j.eururo.2006.07.004 · DOI · Paper page
  127. Serefoglu, 2011, Prevalence of the complaint of ejaculating prematurely and the four premature ejaculation syndromes: results from the Turkish Society of Andrology Sexual Health Survey, J Sex Med, 8, 540, 10.1111/j.1743-6109.2010.02095.x · DOI · Paper page
  128. Gao, 2013, Prevalence and factors associated with the complaint of premature ejaculation and the four premature ejaculation syndromes: a large observational study in China, J Sex Med, 10, 1874, 10.1111/jsm.12180 · DOI · Paper page
  129. Althof, 2014, An update of the International Society of Sexual Medicine’s guidelines for the diagnosis and treatment of premature ejaculation (PE), J Sex Med, 11, 1392, 10.1111/jsm.12504 · DOI · Paper page
  130. Rowland, 1997, Premature ejaculation: psychophysiological considerations in theory, research, and treatment, Annu Rev Sex Res, 8, 224, 10.1080/10532528.1997.10559923 · DOI
  131. Giuliano, 2008, Premature ejaculation: results from a five-country European observational study, Eur Urol, 53, 1048, 10.1016/j.eururo.2007.10.015 · DOI · Paper page
  132. Kempeneers, 2013, Functional and psychological characteristics of Belgian men with premature ejaculation and their partners, Arch Sex Behav, 42, 51, 10.1007/s10508-012-9958-y · DOI
  133. Rosen, 2007, Correlates to the clinical diagnosis of premature ejaculation: results from a large observational study of men and their partners, J Urol, 177, 1059, 10.1016/j.juro.2006.10.044 · DOI · Paper page
  134. Waldinger, 2008, Geometric mean IELT and premature ejaculation: appropriate statistics to avoid overestimation of treatment efficacy, J Sex Med, 5, 492, 10.1111/j.1743-6109.2007.00696.x · doi:10.1111/j.1743-6109.2007.00696.x
  135. Symonds, 2007, Development and validation of a premature ejaculation diagnostic tool, Eur Urol, 52, 565, 10.1016/j.eururo.2007.01.028 · DOI · Paper page
  136. Arafa, 2007, Development and evaluation of the Arabic Index of Premature Ejaculation (AIPE), J Sex Med, 4, 1750, 10.1111/j.1743-6109.2006.00213.x · DOI
  137. Lue, 2004, Summary of the recommendations on sexual dysfunctions in men, J Sex Med, 1, 6, 10.1111/j.1743-6109.2004.10104.x · DOI · Paper page
  138. Porst, 2010, Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: integrated analyses of two phase 3 dapoxetine trials, J Sex Med, 7, 2231, 10.1111/j.1743-6109.2010.01820.x · DOI
  139. Castiglione, 2016, Current pharmacological management of premature ejaculation: a systematic review and meta-analysis, Eur Urol, 69, 904, 10.1016/j.eururo.2015.12.028 · DOI
  140. Pryor, 2006, Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials, Lancet Lond Engl, 368, 929, 10.1016/S0140-6736(06)69373-2 · DOI · Paper page
  141. McMahon, 2016, The Asia-Pacific flexible dose study of dapoxetine and patient satisfaction in premature ejaculation therapy: the PASSION study, Sex Med, 4, e18, 10.1016/j.esxm.2015.12.006 · DOI
  142. Yue, 2015, Efficacy of dapoxetine for the treatment of premature ejaculation: a meta-analysis of randomized clinical trials on intravaginal ejaculatory latency time, patient-reported outcomes, and adverse events, Urology, 85, 856, 10.1016/j.urology.2015.01.009 · doi:10.1016/j.urology.2015.01.009
  143. Qin, 2019, Safety and efficacy characteristics of oral drugs in patients with premature ejaculation: a Bayesian network meta-analysis of randomized controlled trials, Int J Impot Res, 31, 356, 10.1038/s41443-019-0146-7 · DOI
  144. Henry, 2008, TEMPE: topical eutectic-like mixture for premature ejaculation, Expert Opin Drug Deliv, 5, 251, 10.1517/17425247.5.2.251 · DOI
  145. Dinsmore, 2007, Topical eutectic mixture for premature ejaculation (TEMPE): a novel aerosol-delivery form of lidocaine-prilocaine for treating premature ejaculation, BJU Int, 99, 369, 10.1111/j.1464-410X.2006.06583.x · DOI · Paper page
  146. Waldinger, 2018, Drug treatment options for premature ejaculation, Expert Opin Pharmacother, 19, 1077, 10.1080/14656566.2018.1494725 · doi:10.1080/14656566.2018.1494725
  147. Morales, 2012, Evolving therapeutic strategies for premature ejaculation: the search for on-demand treatment—topical versus systemic, Can Urol Assoc J, 6, 380, 10.5489/cuaj.12002 · DOI
  148. Jian, 2018, Pharmacotherapy of premature ejaculation: a systematic review and network meta-analysis, Int Urol Nephrol, 50, 1939, 10.1007/s11255-018-1984-9 · DOI
  149. Waldinger, 1998, Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline, J Clin Psychopharmacol, 18, 274, 10.1097/00004714-199808000-00004 · DOI · Paper page
  150. Zhang, 2019, Paroxetine in the treatment of premature ejaculation: a systematic review and meta-analysis, BMC Urol, 19, 2, 10.1186/s12894-018-0431-7 · DOI
  151. Wu, 2021, Tolerability and optimal therapeutic dosage of clomipramine for premature ejaculation: a systematic review and meta-analysis, Sex Med, 9
  152. Yi, 2019, Efficacy and safety of sertraline for the treatment of premature ejaculation: systematic review and meta-analysis, Medicine (Baltimore), 98, 10.1097/MD.0000000000015989 · doi:10.1097/md.0000000000015989
  153. Martyn-St James, 2015, Tramadol for premature ejaculation: a systematic review and meta-analysis, BMC Urol, 15, 6, 10.1186/1471-2490-15-6 · DOI
  154. Sharma, 2021, Safety and efficacy of “on-demand” tramadol in patients with premature ejaculation: an updated meta-analysis, Int Braz J Urol, 47, 10.1590/s1677-5538.ibju.2020.0561 · DOI
  155. Bar-Or, 2012, A randomized double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of two doses of the tramadol orally disintegrating tablet for the treatment of premature ejaculation within less than 2 minutes, Eur Urol, 61, 736, 10.1016/j.eururo.2011.08.039 · DOI
  156. Kirby, 2015, Tramadol for the management of premature ejaculation: a timely systematic review, Int J Impot Res, 27, 121, 10.1038/ijir.2015.7 · doi:10.1038/ijir.2015.7
  157. Hamidi-Madani, 2018, The efficacy and safety of on-demand tramadol and paroxetine use in treatment of life long premature ejaculation: a randomized double-blind placebo-controlled clinical trial, J Reprod Infertil, 19, 10
  158. Sridharan, 2018, Pharmacological interventions for premature ejaculation: a mixed-treatment comparison network meta-analysis of randomized clinical trials, Int J Impot Res, 30, 215, 10.1038/s41443-018-0030-x · DOI
  159. Martyn-St James, 2017, Phosphodiesterase type 5 inhibitors for premature ejaculation: a systematic review and meta-analysis, Eur Urol Focus, 3, 119, 10.1016/j.euf.2016.02.001 · DOI
  160. Liu, 2020, Comparative efficacy and safety of drug treatment for premature ejaculation: a systemic review and Bayesian network meta-analysis, Andrologia, 52, 10.1111/and.13806 · DOI
  161. Althof, 2016, Psychosexual therapy for premature ejaculation, Transl Androl Urol, 5, 475, 10.21037/tau.2016.05.15 · DOI
  162. Ventus, 2020, Vibrator-assisted start–stop exercises improve premature ejaculation symptoms: a randomized controlled trial, Arch Sex Behav, 49, 1559, 10.1007/s10508-019-01520-0 · DOI
  163. Stephenson, 2020, Statistical mediators of the association between mindfulness and sexual experiences in men with impaired sexual function, Arch Sex Behav, 49, 1545, 10.1007/s10508-019-01467-2 · DOI
  164. Cormio, 2015, The combination of dapoxetine and behavioral treatment provides better results than dapoxetine alone in the management of patients with lifelong premature ejaculation, J Sex Med, 12, 1609, 10.1111/jsm.12925 · DOI
  165. Mulhall, 1995, Hemospermia: diagnosis and management, Urology, 46, 463, 10.1016/S0090-4295(99)80256-8 · doi:10.1016/s0090-4295(99)80256-8
  166. Ng, 2013, Haematospermia as a presenting symptom: outcomes of investigation in 300 men, Surgeon, 11, 35, 10.1016/j.surge.2012.04.004 · doi:10.1016/j.surge.2012.04.004
  167. Kumar, 2006, Haematospermia—a systematic review, Ann R Coll Surg Engl, 88, 339, 10.1308/003588406X114749 · doi:10.1308/003588406x114749
  168. Efesoy O, Çayan S, Aşcı R, Orhan İ, Yaman Ö. Hematospermia is rarely related to genitourinary cancer: lessons learned from 15 years of experience with 342 cases. Int J Impot Res. In press. https://doi.org/10.1038/s41443-020-0330-9. · doi:10.1038/s41443-020-0330-9
  169. Bamberger, 2005, Detection of sexually transmitted pathogens in patients with hematospermia, Isr Med Assoc J IMAJ, 7, 224
  170. Bhaduri, 1999, Haematospermia associated with malignant hypertension, Sex Transm Infect, 75, 200, 10.1136/sti.75.3.200 · doi:10.1136/sti.75.3.200
  171. Amasanti, 2017, Hematospermia as a manifestation of severe hypertension in a young man, Clin Case Rep, 5, 446, 10.1002/ccr3.849 · doi:10.1002/ccr3.849
  172. Munkel Witz, 1997, Current perspectives on hematospermia: a review, J Androl, 18, 6, 10.1002/j.1939-4640.1997.tb01870.x · doi:10.1002/j.1939-4640.1997.tb01870.x
  173. Manohar, 2008, Transrectal ultrasound- and fluoroscopic-assisted transurethral incision of ejaculatory ducts: a problem-solving approach to nonmalignant hematospermia due to ejaculatory duct obstruction, J Endourol, 22, 1531, 10.1089/end.2007.0415 · doi:10.1089/end.2007.0415
  174. Suh, 2017, Etiologic classification, evaluation, and management of hematospermia, Transl Androl Urol, 6, 959, 10.21037/tau.2017.06.01 · doi:10.21037/tau.2017.06.01
  175. Ahmad, 2007, Hemospermia, J Urol, 177, 1613, 10.1016/j.juro.2007.01.004 · doi:10.1016/j.juro.2007.01.004
  176. Han, 2004, Association of hemospermia with prostate cancer, J Urol, 172, 2189, 10.1097/01.ju.0000144565.76243.b1 · doi:10.1097/01.ju.0000144565.76243.b1
  177. Mittal, 2016, Hematospermia evaluation at MR imaging, Radiographics, 36, 1373, 10.1148/rg.2016150195 · doi:10.1148/rg.2016150195
  178. Expert Panel on Urologic Imaging, 2017, ACR appropriateness Criteria® hematospermia, J Am Coll Radiol, 14, S154, 10.1016/j.jacr.2017.02.023 · doi:10.1016/j.jacr.2017.02.023
  179. Li, 2013, Clinical analysis of the characterization of magnetic resonance imaging in 102 cases of refractory haematospermia, Andrology, 1, 948, 10.1111/j.2047-2927.2013.00132.x · doi:10.1111/j.2047-2927.2013.00132.x

Cited by

See all 828

Metadata

Authors
Salonia, A., Bettocchi, C., Boeri, L., Capogrosso, P., Carvalho, J., Cilesiz, N. C., Cocci, A., Corona, G., Dimitropoulos, K., Gül, M., Hatzichristodoulou, G., Jones, T. H., Kadioglu, A., Martínez Salamanca, J. I., Milenkovic, U., Modgil, V., Russo, G. I., Serefoglu, E. C., Tharakan, T., Verze, P., & Minhas, S.
Venue
European Urology
Publisher
Elsevier BV
Published
2021-09
Volume
80
Issue
3
Pages
333-357
ISSN
0302-2838 (ISSN-L)
DOI
10.1016/j.eururo.2021.06.007
OpenAlex
W3173550964
Cited by
828
References
29
FWCI
83.13
Type
journal article
Language
en
Open access
green
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
European Association of Urology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: European Association of Urology Guidelines on Sexual and Reproductive Health—2021 Update: Male Sexual Dysfunction. https://app.cochat.ai/papers/10.1016/j.eururo.2021.06.007
The paper
Salonia, A., Bettocchi, C., Boeri, L., Capogrosso, P., Carvalho, J., Cilesiz, N. C., Cocci, A., Corona, G., Dimitropoulos, K., Gül, M., Hatzichristodoulou, G., Jones, T. H., Kadioglu, A., Martínez Salamanca, J. I., Milenkovic, U., Modgil, V., Russo, G. I., Serefoglu, E. C., Tharakan, T., . . . Minhas, S. (2021). European Association of Urology Guidelines on Sexual and Reproductive Health—2021 Update: Male Sexual Dysfunction. European Urology. https://doi.org/10.1016/j.eururo.2021.06.007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.